(Press-News.org) HOUSTON (June 2, 2011) – The protein MeCP2 is porridge to the finicky neuron. Like Goldilocks, the neuron or brain cell needs the protein in just the right amount. Girls born with dysfunctional MeCP2 (methyl-CpG-binding protein 2) develop Rett syndrome, a neurological disorder. Too much MeCP2 can cause spasticity or developmental delay with autism-like symptoms in boys.
Now, researchers at Baylor College of Medicine (www.bcm.edu) and Texas Children's Hospital (www.texaschildrens.org) have found that the neuron needs a steady supply of this protein for its entire existence. A report on this research appears online in Science Express (http://www.sciencemag.org/content/early/recent).
MeCP2 was found in 1999 in the laboratory of Dr. Huda Zoghbi (http://www.bcm.edu/genetics/index.cfm?pmid=11053), director of the Jan and Dan Duncan Neurological Research Institute at TCH (http://www.nri.texaschildrens.org/) and professor of neurology, neuroscience, pediatrics and molecular and human genetics at BCM and a Howard Hughes Medical Institute Investigator. A mutation in MeCP2 results in Rett syndrome, a neurological disorder that strikes mainly girls. Male fetuses born with the mutation (which results in dysfunctional protein) die before birth, but girls appear normal until they are between 6 and 18 months. Then they begin to regress and their growth slows. They develop abnormal hand motions such as wringing. Their crawling and walking regresses and they eventually lose the ability to speak or communicate. They exhibit some symptoms of autism.
Clearly, MeCP2 is critical to normal mental functioning, but a question remained. Do neurons need MeCP2 throughout life or would they be protected and work properly if MeCP2 is provided only early in life and then discontinued during adulthood?
To the surprise of Zoghbi and M.D./Ph.D. student Christopher McGraw (http://www.bcm.edu/mstp/students/mcgraw_chris.html), the paper's first author, the neurons need the protein throughout life.
"To continue the porridge analogy, taking it away puts you in the same position as someone who never had it," said McGraw.
To demonstrate this, they developed a mouse from which they could eliminate MeCP2 in adulthood.
"We found that they appeared just like the mice born without the protein," said McGraw. The mice developed the Rett-like behaviors, including the limb "clasping" behavior and impaired learning and memory. The mice also died prematurely, 13 weeks after the protein was deleted. Mice born lacking the protein die at about 13 weeks of age as well.
"What this suggests is that the function of this protein is always needed," said McGraw. "Having this protein up to adulthood does not result in the construction of a nervous system that is any more resilient to the loss of MeCP2 than one born without it."
"That was the most surprising to us," said Zoghbi. "The upside of this is if you can add the protein back, you can rescue the neurons, which is indeed what happened when the lab of Dr. Adrian Bird, researcher with the Wellcome Trust Center for Cell Biology, added the gene back in adults in past research," she said. "The new study shows there are no developmental abnormalities. It is all about needing the protein right there to tell the neurons what to do."
MeCP2 affects the epigenetic program of the cell, changing the expression levels of certain genes without changing the sequence of the DNA itself. Scientists are still trying to determine exactly what it does in the cell, and that may enable physicians to develop a treatment that patients would take throughout their lives.
"If we can figure a way to provide the functions of this protein we have a chance to treat these patients successfully and maintain their health," she said.
Just giving patients MeCP2 would not work because of the need to fine-tune the amount of protein in the cell.
She and colleagues are looking instead for drugs that can serve the same function as MeCP2 or that can alter the pathways through which this gene works.
Dr. Rodney C. Samaco of BCM also participated in this research.
###
Funding for this work came from the National Institutes of Health (www.nih.gov), the Baylor College of Medicine Research Advocates for Student Scientists (http://www.bcm.edu/advancement/index.cfm?PMID=17692), the International Rett Syndrome Foundation (http://www.rettsyndrome.org), the Simons Foundation (www.simonsfoundation.org) and the Rett Syndrome Research Trust (http://www.rsrt.org/).
For more information on basic science research at Baylor College of Medicine, please go to www.bcm.edu/fromthelab.
Graciela Gutierrez
ggutierr@bcm.edu
713-798-4710
www.bcm.edu/news
Christy Brunton
clbrunto@texaschildrens.org
832-824-2645
www.texaschildrens.org
END
TUCSON, Ariz. (June 2, 2011) -- In just 10 weeks, a group of University of Arizona engineering students took five crates of surplus hardware and two heavy-duty test vehicles, which didn't run, and mixed them with youthful enthusiasm, tenacity and many long hours to build two robotic vehicles that successfully drove themselves around UA's test mine.
It was no easy task, and predicted by some as too big a project for a one semester course: ENGR 450/550, autonomous vehicle systems. But the naysayers didn't factor in the can-do attitude of 23 undergraduate and graduate students ...
2 players have struck it lucky at Sun Vegas Internet Casino on Monday the 30th May 2011. JK won CAD 23,373.50 playing on the video slot game Thunderstruck; CAD 21,453.50 on the 5-reel slot, Ladies Nite; and CAD 9,995.00 on the Egyptian-themed game, ISIS. Thus JK walked away with total winnings of CAD 54,822.00. Another winner, NJ, won $16,187.40 on Break Da Bank Again and $5,868.00 on Mega Moolah Summertime Progressive, giving her a total of $22,055.40.
Casino Manager at Sun Vegas Casino, Austin Green, said, "Two winners in one day is what makes Sun Vegas Casino ...
New research identifies genetic mutations that cause an inherited form of cataracts in humans. The study, published online June 2 by Cell Press in the American Journal of Genetics, provides new insight into the understanding of lens transparency and the development of cataracts in humans.
A cataract is a clouding of the crystalline lens in the eye. Opacity of the normally transparent lens obstructs the passage of light into the eye and can lead to blindness. Congenital cataracts (CCs) are a significant cause of vision loss worldwide and underlie about one-third of the ...
When people are depressed or anxious, they are much more likely to see their glass as half empty than half full. In tough times, evidence of that same pessimistic outlook can be seen in dogs, rats, and birds. Now, researchers reporting online on June 2 in Current Biology, a Cell Press publication, show that bees, too, share those very same hallmarks of negative emotion.
"We have shown that the emotional responses of bees to an aversive event are more similar to those of humans than previously thought," said Geraldine Wright of Newcastle University. "Bees stressed by a ...
Following a spate of bookings during the last month, things are certainly looking rosier in terms of luxury yacht charter and the news regarding luxury yacht sales is similarly encouraging with an increase in numbers compared to the same period last year. Unfortunately the majority of these sales have been in the 24-35m categories, which represents the smaller end of the market, so while the volume is up the overall value of the market is somewhat down.
Fortunately, however, over the last few days' negotiations have been completed with regard to a number of very large ...
SAN FRANCISCO, CA—June 2, 2011—Scientists at the Gladstone Institutes have identified a drug candidate that diminishes the effects of both Alzheimer's disease and Huntington's disease in animal models, offering new hope for patients who currently lack any medications to halt the progression of these two debilitating illnesses.
Gladstone Investigator Paul Muchowski, PhD, has identified a new compound called JM6 in experiments done in collaboration with an international team of researchers, and which are being published today in an online article in Cell. In laboratory ...
Levels of C-reactive protein (CRP) are increased in response to acute inflammation, infection and tissue damage. There are also reports that CRP levels are elevated because of cancer. New research published in BioMed Central's open access journal Breast Cancer Research shows that elevated CRP levels are predictive of a poor prognosis for breast cancer sufferers.
C-reactive protein is produced by the liver, in response to infection or injury, when stimulated by the cytokine IL-6. Tumor sites are often associated with inflammation and this inflammation contributes to tumor ...
Researchers at King's College London have identified a way of eliminating leukaemic stem cells, which could lead to new treatments that may enable complete remission for leukaemia patients. An early study in mice has shown that leukaemic stem cells can be abolished by suppressing two proteins found in the body.
Leukaemic stem cells sustain the disease and are likely to be responsible for relapse, so elimination of these cells is believed to be key for achieving complete remission. These encouraging findings highlight the two proteins as potential therapeutic targets ...
Students overall performed better – and educationally disadvantaged students generally made even greater strides than everyone else – in an introductory biology course at a university where recent budget woes doubled class sizes for the course, cut lab times and reduced the number of graduate teaching assistants.
The keys to success are instructors who guide learning rather than lecture, and who structure courses so students are more likely to come to class having read assignments and where they undergo intensive practice to develop critical thinking and problem solving ...
Until a decade, it was believed that differences between people were due solely to the existence of genetic changes, which are alterations in the sequence of our genes. The discoveries made during these last ten years show that beings with the same genetics like the twins and cloned animals may have different characteristics and disease due to epigenetic changes.
Epigenetics involves chemical signatures that are added to DNA and proteins that package it, to regulate their activity. The more recognized epigenetic brand is DNA methylation, a process based on the addition ...
